Trials / Unknown
UnknownNCT03515863
Natural History and Risk Factors of TAO
Natural History and Genetic Risk Factors of Thyroid Associated Ophthalmopathy (TAO)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to complete the identification of genetic factors predisposing to thyroid associated ophthalmopathy (TAO) by constituting a cohort of 400 Grave's patients with or without ocular signs.
Detailed description
Graves' disease (GD) is a common autoimmune condition, and its ocular condition is known as thyroid-associated ophthalmopathy (TAO). There is considerable evidence that both genetic and environmental factors are involved in the development of TAO. We conduct a study of 400 Grave's patients, with or without TAO, and obtain the following data: genetic tests, ocular imaging and life style information. Genetic tests are obtained by collection of blood samples for DNA extraction, whole-genome sequencing, and identification of cellular biomarkers, using transcriptomics and mass cytometry. Ocular imaging data are collected from Orbit MRI examination. Life style data are collected using a standardized questionnaire.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | DNA extraction and genetic characterization | Collection of blood samples for DNA extraction and genetic characterization using whole-genome sequencing, and for identification of cellular biomarkers using transcriptomics and mass cytometry. |
| DEVICE | Orbit MRI examination | Orbit MRI examination is performed to confirm the diagnosis of TAO |
| OTHER | Collection of life style data | Collection of life style data using quality of life questionnaire |
Timeline
- Start date
- 2018-05-15
- Primary completion
- 2021-05-09
- Completion
- 2022-05-09
- First posted
- 2018-05-04
- Last updated
- 2019-09-23
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03515863. Inclusion in this directory is not an endorsement.